PeerVoice Endocrinology & Metabolic Disorders Video

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 22m. Bisher sind 128 Folge(n) erschienen. Alle zwei Wochen gibt es eine neue Folge dieses Podcasts.

Gesamtlänge aller Episoden: 2 days 6 hours 13 minutes

subscribe
share






Defining the Role of SGLT2 Inhibitors for Your Patient With Type 2 Diabetes


Defining the Role of SGLT2 Inhibitors for Your Patient With Type 2 Diabetes


share








 December 19, 2014  19m
 
 

Secretory Pituitary Adenomas: What Are the New Treatment Options on the Horizon?


Secretory Pituitary Adenomas: What Are the New Treatment Options on the Horizon?


share








 October 1, 2014  28m
 
 

Stepping Up Care for Acromegaly With Early Diagnosis and Emerging Therapeutic Options


Go online to www.peervoice.com/h/pvr116 to view the entire programme with slides.


share








 May 30, 2014  20m
 
 

Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?


Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?


share








 January 1, 1970  16m
 
 

Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?


Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?


share








 January 1, 1970  24m
 
 

Let Their Feet Lead the Way: Tools for Early Identification of FOP


Let Their Feet Lead the Way: Tools for Early Identification of FOP


share








 January 1, 1970  22m
 
 

Individualising Glycaemic Targets in Type 2 Diabetes and Obesity: A Case-Based Approach


Individualising Glycaemic Targets in Type 2 Diabetes and Obesity: A Case-Based Approach


share








 January 1, 1970  21m
 
 

State of the Science in CKD: New Treatment, New Outcomes


State of the Science in CKD: New Treatment, New Outcomes


share








 January 1, 1970  17m